Prevention, awareness and infrastructure
Across the world, and particularly in developing countries, people affected by certain diseases face stigma and discrimination, disability and a vicious cycle of ill health and poverty.
Diseases that can be prevented, managed, or cured cause significant suffering and mortality due to a lack of basic knowledge and inadequate health services.
To improve healthcare access and support people in vulnerable communities, we make targeted product and financial donations to programmes run by local and global partners that are designed to be sustainable in the long term. We also partner with NGOs to tackle some of the root causes of disease and ill health. Our philosophy is to support health and educational programmes that are innovative, sustainable and produce tangible results.
Save the Children
We have an?innovative ten-year?partnership with Save the Children?to help save one million children’s lives.? We are combining GSK’s scientific and manufacturing expertise with Save the Children’s on-the-ground experience to find new ways to help bring down the number of children dying from preventable and treatable?diseases. In the next few years, by focusing on running long-term health programmes, strengthening countries’ healthcare systems, finding new treatments and advocating for global change, we can help build a world where no child under the age of five dies from preventable causes.
To date, we have reached over 2.95 million children in 46 countries through our partnership. Over 118,000 children under-five have been fully immunised and over 258,000 children have been treated for diarrhoea, malaria or pneumonia.?Find out more about our partnership with Save the Children
We've reached over 2.95 million children through our partnership with Save the Children
Meet Baby Mckline
The first baby born at a healthcare facility in Bungoma County, Kenya, supported through our partnership with Save the Children.
Healthcare worker training
The world is expected to be short of 18 million health workers by 2030; the shortage is most acute in the world’s poorest countries and is recognised as one of the most fundamental barriers to good health. A fully trained and well-supported community health worker can effectively deliver treatments for common childhood illnesses and provide health education reaching up to 500 children in a year.
The Frontline Health Worker Programme is a partnership between GSK, Amref Health Africa, CARE International and Save the Children, which is working to address the chronic global shortage of health workers.
It is an ambitious partnership, implementing sustainable healthcare programmes in communities across Africa and Asia and advocating for affordable, quality healthcare, for everyone, everywhere.
Our programmes train frontline health workers not only to treat individuals but to connect communities to the wider health system, for example, by helping people access more specialised healthcare outside of their community. Our partnership represents one of the biggest private sector-NGO partnerships in the world focussed on frontline health workers. Since 2009, together, we have invested ￡43m, funded by GSK, to train over 86,000 frontline health workers in 44 countries.
Every year millions of people are displaced by disasters and emergency situations. These crises can devastate families, leaving them without access to adequate food, shelter or healthcare. GSK works with partners and humanitarian organisations to prepare for and respond to emergency situations. In some instances, we fast-track the development of life-saving vaccines, and in others, we contribute by donating cash, products and our employees’ time. We also invest in long-term rebuilding and?reconstruction in the aftermath of a disaster. Since 2012 we have provided ￡2.1 million in cash and product donations to support refugees.
GSK Consumer Healthcare, with its heritage in specialist oral health, is supporting a new partnership with Smile Train, a world-leading charity which empowers local medical professionals to provide free, life-changing surgery and comprehensive cleft care to children with cleft lip and palate in more than 85 countries. Over 5 years, we are providing Smile Train with valuable funding, support and expertise to help more children living with clefts lead full and productive lives, as well as helping increase awareness and education about cleft.
Our partnership with UK charity Comic?Relief,?aims to fight malaria and strengthen health systems. The ￡22 million partnership, created by a ￡17 million donation from GSK and ￡5 million from Comic Relief, makes grants to frontline organisations in five?malaria endemic?countries. This complements interventions by other global health funders and grassroots organisations. Projects range from youth-led approaches to increase malaria awareness, to?training?of frontline community healthcare workers and volunteers.? To?date?this has benefited over 1 million people.?
Our PULSE Volunteer Partnership provides a skills-based volunteering opportunity for eligible GSK employees to be matched with a non-profit organisation for three or six months full-time. Since 2009, PULSE has contributed a total ￡22 million worth of skilled services to nonprofit organisations across the world.
ViiV Healthcare’s Positive Action programmes continue to make great progress through community partnerships, connections and collaborations with the broader HIV community. Funding enables these communities to:
- tackle stigma and discrimination and reduce violence against at-risk populations
- test innovations in education, care and treatment
- build the grassroots capacity of these disproportionately affected communities.
Find out more
Using our science for global health
Utilising our scientific expertise, our partnerships and our global reach to make products available for people who need them, wherever they live
Preparing for future disease threats
We work to tackle some of the root causes of disease and contribute to healthier communities around the world
Pricing and access strategies
We are making our products affordable and available to more people around the world through responsible pricing, and strategic access programmes and partnerships.
Improving health globally
Millions of people live with unmet healthcare needs. We want to help change this, using our scientific expertise, our partnerships and our global reach.